We serve Chemical Name:2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol CAS:1173019-61-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol](https://a.dearchem.com/CAS2/1173019-61-8.png)
Chemical Name:2-[4-(3,6-dimethylheptan-3-yl)phenoxy]ethanol
CAS.NO:1173019-61-8
Synonyms:363-NP1EO-13C6;3,6,3-Nonylphenol-monoethoxylate-13C6
Molecular Formula:C17H28O2
Molecular Weight:270.35900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.46000
Exact Mass:270.22900
LogP:4.16160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1090 3/PG 2
Packing Group:
Contact us for information like 363-NP1EO-13C6 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,6,3-Nonylphenol-monoethoxylate-13C6 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,6,3-Nonylphenol-monoethoxylate-13C6 Use and application,3,6,3-Nonylphenol-monoethoxylate-13C6 technical grade,usp/ep/jp grade.
Related News: The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 6-hydroxy-7-(((2E,5E)-7-hydroxy-3,7-dimethylocta-2,5-dien-1-yl)oxy)-2H-chromen-2-one manufacturers IDA Ireland Executive Director Mary Buckley said: “Charles River is an employer of long-standing in Co. Mayo. The enhancement of its product lines and the development of additional capability at the Ballina facility is most welcome. N-(2,4-dibromo-6-methyl-phenyl)-N-(5-methyl-4,5-dihydro-thiazol-2-yl)-methanesulfonamide suppliers In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. 4-(6-chlorobenzo[b]thiophen-2-yl)-N-(3-(2-(diisopropylamino)ethoxy)-4-methoxyphenyl)piperazine-1-carboxamide vendor & factory.
